Industry Experience of Multi-Stakeholder Early Advice Consultations, PPT by J. Anderson

Presentation at ISPOR Europe, Nov. 2011, by James S. Anderson, MA, MBA, European Partnerships Director, Government Affairs, Public Policy and Patient Advocacy, GlaxoSmithKline, Brentford, UK

You might also be interested in:

NICE Provides First Advice on Patient Preference Study Design February 15, 2019
ISPOR Releases Final Program, Speakers for ISPOR Europe 2018 October 31, 2018
HTA in Europe: Key Success Factors for Positive HTA Recommendations June 21, 2018
Proposed HTA Regulation Gets Warm Welcome from Trade Groups June 27, 2018
Cochrane Spotlights Key Partnerships December 5, 2018
Orphan Drugs: European Payer Perspectives October 14, 2018
Orphan Drugs: European Payer Perspectives October 14, 2018